BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kemp CD, Conte JV. The pathophysiology of heart failure. Cardiovasc Pathol. 2012;21:365-371. [PMID: 22227365 DOI: 10.1016/j.carpath.2011.11.007] [Cited by in Crossref: 212] [Cited by in F6Publishing: 177] [Article Influence: 21.2] [Reference Citation Analysis]
Number Citing Articles
1 Stewart RH. A Modern View of the Interstitial Space in Health and Disease. Front Vet Sci 2020;7:609583. [PMID: 33251275 DOI: 10.3389/fvets.2020.609583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tuet WY, Pierce SA, Racine MC, Stone S, Pueblo E, Dukes A, Tressler J, Jennings L, McCranor BJ, Wong B. Cardiopulmonary effects of phosphine poisoning: A preliminary evaluation of milrinone. Toxicol Appl Pharmacol 2021;427:115652. [PMID: 34298059 DOI: 10.1016/j.taap.2021.115652] [Reference Citation Analysis]
3 Straw S, Witte KK, Kearney MT. Heart failure: A preventable and treatable complication of type 2 diabetes. J Diabetes 2019;11:613-6. [PMID: 31037815 DOI: 10.1111/1753-0407.12930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sabbah HN. Silent disease progression in clinically stable heart failure. Eur J Heart Fail 2017;19:469-78. [PMID: 27976514 DOI: 10.1002/ejhf.705] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
5 Urmaliya V, Franchelli G. A multidimensional sight on cardiac failure: uncovered from structural to molecular level. Heart Fail Rev 2017;22:357-70. [PMID: 28474325 DOI: 10.1007/s10741-017-9610-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Parajuli N, Ramprasath T, Patel VB, Wang W, Putko B, Mori J, Oudit GY. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases. Can J Physiol Pharmacol 2014;92:558-65. [PMID: 24861775 DOI: 10.1139/cjpp-2013-0488] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
7 Dedkov EI, Bogatyryov Y, Mccooey DS, Christensen LP, Weiss RM, Tomanek RJ. Effect of Chronic Heart Rate Reduction by I f Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure. J Cardiovasc Pharmacol Ther 2015;20:299-312. [DOI: 10.1177/1074248414553231] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Wang X, Zhao M, Wang X, Li S, Cao N, Liu H. The Application of Dynamic Models to the Exploration of β1-AR Overactivation as a Cause of Heart Failure. Comput Math Methods Med 2018;2018:1613290. [PMID: 30154911 DOI: 10.1155/2018/1613290] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Bernal-Ceballos F, Wacher-Rodarte NH, Orea-Tejeda A, Hernández-Gilsoul T, Castillo-Martínez L. Bioimpedance vector analysis in stable chronic heart failure patients: Level of agreement between single and multiple frequency devices. Clin Nutr ESPEN 2021;43:206-11. [PMID: 34024516 DOI: 10.1016/j.clnesp.2021.04.015] [Reference Citation Analysis]
10 Thassakorn P, Patchanee P, Pongkan W, Chattipakorn N, Boonyapakorn C. Effect of atorvastatin on oxidative stress and inflammation markers in myxomatous mitral valve disease in dogs: A comparison of subclinical and clinical stages. J Vet Pharmacol Ther 2019;42:258-67. [PMID: 30666669 DOI: 10.1111/jvp.12746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Masoud WGT, Clanachan AS, Lopaschuk GD. The Failing Heart: Is It an Inefficient Engine or an Engine Out of Fuel? In: Jugdutt BI, Dhalla NS, editors. Cardiac Remodeling. New York: Springer; 2013. pp. 65-84. [DOI: 10.1007/978-1-4614-5930-9_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Díez J, Ruilope LM. Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection. Eur Heart J Cardiovasc Pharmacother 2016;2:119-30. [PMID: 27418970 DOI: 10.1093/ehjcvp/pvv046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
13 Abdin A, Anker SD, Butler J, Coats AJS, Kindermann I, Lainscak M, Lund LH, Metra M, Mullens W, Rosano G, Slawik J, Wintrich J, Böhm M. 'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor. ESC Heart Fail 2021. [PMID: 34655282 DOI: 10.1002/ehf2.13646] [Reference Citation Analysis]
14 Janaswamy P, Walters TE, Nazer B, Lee RJ. Current Treatment Strategies for Heart Failure: Role of Device Therapy and LV Reconstruction. Curr Treat Options Cardiovasc Med 2016;18:57. [PMID: 27488313 DOI: 10.1007/s11936-016-0479-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Rosen D, Roux FJ, Shah N. Sleep and breathing in congestive heart failure. Clin Chest Med 2014;35:521-34. [PMID: 25156768 DOI: 10.1016/j.ccm.2014.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Radhachandran A, Garikipati A, Zelin NS, Pellegrini E, Ghandian S, Calvert J, Hoffman J, Mao Q, Das R. Prediction of short-term mortality in acute heart failure patients using minimal electronic health record data. BioData Min 2021;14:23. [PMID: 33789700 DOI: 10.1186/s13040-021-00255-w] [Reference Citation Analysis]
17 Sheikh O, Nashawi M, Battisha A, Chilton R. A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA. Cardiovasc Endocrinol Metab 2020;9:36-41. [PMID: 32537563 DOI: 10.1097/XCE.0000000000000192] [Reference Citation Analysis]
18 Blackburn NJ, Sofrenovic T, Kuraitis D, Ahmadi A, Mcneill B, Deng C, Rayner KJ, Zhong Z, Ruel M, Suuronen EJ. Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarction. Biomaterials 2015;39:182-92. [DOI: 10.1016/j.biomaterials.2014.11.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
19 Sang L, Yuan Y, Zhou Y, Zhou Z, Jiang M, Liu X, Hao K, He H. A quantitative systems pharmacology approach to predict the safe-equivalent dose of doxorubicin in patients with cardiovascular comorbidity. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34596967 DOI: 10.1002/psp4.12719] [Reference Citation Analysis]
20 Papademetriou V, Toumpourleka M, Imprialos KP, Alataki S, Manafis A, Stavropoulos K. The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction. CPD 2019;24:5517-24. [DOI: 10.2174/1381612825666190219141326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Freitas NCC, Cherchiglia ML, Simão Filho C, Alvares-Teodoro J, Acurcio FA, Guerra Junior AA. Sixteen Years of Heart Transplant in an Open Cohort in Brazil: Analysis of Graft Survival of Patients using Immunosuppressants. Arq Bras Cardiol 2021;116:744-53. [PMID: 33886722 DOI: 10.36660/abc.20200117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Ragusa R, Di Molfetta A, Amodeo A, Trivella MG, Caselli C. Pathophysiology and molecular signalling in pediatric heart failure and VAD therapy. Clin Chim Acta 2020;510:751-9. [PMID: 32949569 DOI: 10.1016/j.cca.2020.09.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Boban M, Pesa V, Persic V, Zulj M, Malcic I, Beck N, Vcev A. Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies. Med Sci Monit 2018;24:5084-92. [PMID: 30032158 DOI: 10.12659/MSM.909172] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Curtis AD, Cheng HM. Primer and Historical Review on Rapid Cardiac CINE MRI. J Magn Reson Imaging. [DOI: 10.1002/jmri.27436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ma X, Zhang Q, Zhu H, Huang K, Pang W, Zhang Q. Establishment and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA identifies functional genes in heart failure. Math Biosci Eng 2021;18:4011-26. [PMID: 34198423 DOI: 10.3934/mbe.2021201] [Reference Citation Analysis]
26 Tomsin K, Vriens A, Mesens T, Gyselaers W. Non-invasive cardiovascular profiling using combined electrocardiogram-Doppler ultrasonography and impedance cardiography: An experimental approach. Clin Exp Pharmacol Physiol 2013;40:438-42. [DOI: 10.1111/1440-1681.12105] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
27 Kessler J, Totoson P, Devaux S, Moretto J, Wendling D, Demougeot C. Animal models to study pathogenesis and treatments of cardiac disorders in rheumatoid arthritis: Advances and challenges for clinical translation. Pharmacol Res 2021;170:105494. [PMID: 34139344 DOI: 10.1016/j.phrs.2021.105494] [Reference Citation Analysis]
28 Kazeminezhad B, Tarjoman A, Borji M. Relationship Between Praying and Self-Care in Elderly with Heart Failure: A Cross-Sectional Study in West of Iran. J Relig Health 2020;59:19-28. [DOI: 10.1007/s10943-018-00757-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
29 Habal MV, Garan AR. Long-term management of end-stage heart failure. Best Pract Res Clin Anaesthesiol 2017;31:153-66. [PMID: 29110789 DOI: 10.1016/j.bpa.2017.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
30 Qian K, Zhang L, Li K, Liu J. Editorial: Machine Learning for Non/Less-Invasive Methods in Health Informatics. Front Digit Health 2021;3:763109. [PMID: 34713208 DOI: 10.3389/fdgth.2021.763109] [Reference Citation Analysis]
31 Currie KD, West CR, Stöhr EJ, Krassioukov AV. Left Ventricular Mechanics in Untrained and Trained Males with Tetraplegia. Journal of Neurotrauma 2017;34:591-8. [DOI: 10.1089/neu.2016.4510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
32 Palazzuoli A, Evangelista I, Nuti R. Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload. Heart Fail Rev 2020;25:119-31. [PMID: 31628648 DOI: 10.1007/s10741-019-09868-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
33 Faulkner KM, Uchmanowicz I, Lisiak M, Cichoń E, Cyrkot T, Szczepanowski R. Cognition and Frailty in Patients With Heart Failure: A Systematic Review of the Association Between Frailty and Cognitive Impairment. Front Psychiatry 2021;12:713386. [PMID: 34276454 DOI: 10.3389/fpsyt.2021.713386] [Reference Citation Analysis]
34 Smolka C, Schlösser D, Koentges C, Tarkhnishvili A, Gorka O, Pfeifer D, Bemtgen X, Asmussen A, Groß O, Diehl P, Moser M, Bode C, Bugger H, Grundmann S, Pankratz F. Cardiomyocyte-specific miR-100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36. FASEB J 2021;35:e21956. [PMID: 34605573 DOI: 10.1096/fj.202100829RR] [Reference Citation Analysis]
35 Ishaq S, Lin F, Martins J, Huggett R. Unexpected manifestation of cardiac amyloidosis. BMJ Case Rep 2018;2018:bcr-2017-222852. [PMID: 30077977 DOI: 10.1136/bcr-2017-222852] [Reference Citation Analysis]
36 Russell‐hallinan A, Watson CJ, Baugh JA. Epigenetics of Aberrant Cardiac Wound Healing. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 451-91. [DOI: 10.1002/cphy.c170029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
37 Asano R, Mathai SC, Macdonald PS, Newton PJ, Currow DC, Phillips J, Yeung W, Davidson PM. Oxygen use in chronic heart failure to relieve breathlessness: A systematic review. Heart Fail Rev 2020;25:195-205. [DOI: 10.1007/s10741-019-09814-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
38 Whitehead L. The Family Experience of Fatigue in Heart Failure. J Fam Nurs 2017;23:138-56. [DOI: 10.1177/1074840716684232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
39 Hopper I, Easton K. Chronic heart failure. Aust Prescr 2017;40:128-36. [PMID: 28947850 DOI: 10.18773/austprescr.2017.044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
40 Lv S, Ru S. The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis. PLoS One 2021;16:e0259300. [PMID: 34710169 DOI: 10.1371/journal.pone.0259300] [Reference Citation Analysis]
41 Sifi A, Adi-bessalem S, Laraba-djebari F. Role of angiotensin II and angiotensin type-1 receptor in scorpion venom-induced cardiac and aortic tissue inflammation. Experimental and Molecular Pathology 2017;102:32-40. [DOI: 10.1016/j.yexmp.2016.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
42 Eid PS, Ibrahim DA, Zayan AH, Elrahman MMA, Shehata MAA, Kandil H, Abouibrahim MA, Duy LM, Shinkar A, Elfaituri MK, Minh LHN, Fahmy MM, Tam DNH, Vuong NL, Shah J, Do VBD, Hirayama K, Huy NT. Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials. Heart Fail Rev 2021;26:127-36. [PMID: 32783109 DOI: 10.1007/s10741-020-10003-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Colin-Ramirez E, Ezekowitz JA. Salt in the diet in patients with heart failure: what to recommend. Curr Opin Cardiol. 2016;31:196-203. [PMID: 26595701 DOI: 10.1097/hco.0000000000000253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
44 Chiurchiù V, Leuti A, Saracini S, Fontana D, Finamore P, Giua R, Padovini L, Incalzi RA, Maccarrone M. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes. FASEB j 2018;33:909-16. [DOI: 10.1096/fj.201801017r] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
45 Ge Z, Li A, McNamara J, Dos Remedios C, Lal S. Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies. Heart Fail Rev 2019;24:743-58. [PMID: 31209771 DOI: 10.1007/s10741-019-09806-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
46 Colin-Ramirez E, Arcand J, Woo E, Brum M, Morgan K, Christopher W, Velázquez L, Sharifzad A, Feeney S, Ezekowitz JA. Design and Region-Specific Adaptation of the Dietary Intervention Used in the SODIUM-HF Trial: A Multicentre Study. CJC Open 2020;2:8-14. [PMID: 32159131 DOI: 10.1016/j.cjco.2019.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Chen Y, Gao Y, Zhou Y, Li X, Wang H, Polonsky TS, Vermund SH, Qian HZ, Qian F. Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies. J Acquir Immune Defic Syndr 2021;87:741-9. [PMID: 33492019 DOI: 10.1097/QAI.0000000000002629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Filigheddu F. Genetic prediction of heart failure incidence, prognosis and beta-blocker response. Mol Diagn Ther 2013;17:205-19. [PMID: 23592012 DOI: 10.1007/s40291-013-0035-6] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Chen X, Ma L, Shao M, Wang Q, Jiang Q, Guo D, Zhang P, Yang R, Li C, Wang Y, Wang W. Exploring the protective effects of PNS on acute myocardial ischaemia-induced heart failure by Transcriptome analysis. J Ethnopharmacol 2021;271:113823. [PMID: 33472092 DOI: 10.1016/j.jep.2021.113823] [Reference Citation Analysis]
50 Preedy MEJ, Baliga RS, Hobbs AJ. Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure. J Cardiovasc Pharmacol 2020;75:370-84. [PMID: 31498237 DOI: 10.1097/FJC.0000000000000724] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
51 Cheng H, Wu X, Ni G, Wang S, Peng W, Zhang H, Gao J, Li X. Citri Reticulatae Pericarpium protects against isoproterenol-induced chronic heart failure via activation of PPARγ. Ann Transl Med 2020;8:1396. [PMID: 33313141 DOI: 10.21037/atm-20-2200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Armentaro G, D'Arrigo G, Magurno M, Toscani AF, Condoleo V, Miceli S, Cassano V, Maio R, Arturi F, Tripepi G, Sesti G, Sciacqua A. Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study. Front Pharmacol 2021;12:733475. [PMID: 34483943 DOI: 10.3389/fphar.2021.733475] [Reference Citation Analysis]
53 Fujita B, Zimmermann WH. Myocardial tissue engineering strategies for heart repair: current state of the art. Interact Cardiovasc Thorac Surg 2018;27:916-20. [PMID: 30084989 DOI: 10.1093/icvts/ivy208] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
54 Ferreiro SF, Vilariño N, Carrera C, Louzao MC, Cantalapiedra AG, Santamarina G, Cifuentes JM, Vieira AC, Botana LM. Subacute Cardiovascular Toxicity of the Marine Phycotoxin Azaspiracid-1 in Rats. Toxicol Sci 2016;151:104-14. [PMID: 26865666 DOI: 10.1093/toxsci/kfw025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
55 Ibrahim HMM, Abouelnasr KS, Hamed MA, Eltayesh RA, El-Khodery SA. Comparative Effect of Epidural Administration of Xylazine or Dexmedetomidine on Echocardiographic Dimensions and Cardiac Indices in Clinically Healthy Donkeys (Equus asinus). J Equine Vet Sci 2020;85:102882. [PMID: 31952632 DOI: 10.1016/j.jevs.2019.102882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Aoki T, Yamamoto K. Fundamentals of Physiology and Biology of Vascular System. In: Tanishita K, Yamamoto K, editors. Vascular Engineering. Tokyo: Springer Japan; 2016. pp. 47-68. [DOI: 10.1007/978-4-431-54801-0_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Anand I. Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians. Am J Cardiovasc Drugs 2018;18:333-45. [PMID: 29761293 DOI: 10.1007/s40256-018-0277-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
58 Horvath O, Ordog K, Bruszt K, Deres L, Gallyas F, Sumegi B, Toth K, Halmosi R. BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats. Oxid Med Cell Longev 2021;2021:1250858. [PMID: 33564362 DOI: 10.1155/2021/1250858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Chang TY, Wu YY, Wang VS, Bao BY, Liu CS. Short-term exposure to noise on stroke volume and left ventricular contractility: A repeated-measure study. Environ Pollut 2020;263:114670. [PMID: 33618478 DOI: 10.1016/j.envpol.2020.114670] [Reference Citation Analysis]
60 Usuda D, Higashikawa T, Hotchi Y, Usami K, Shimozawa S, Tokunaga S, Osugi I, Katou R, Ito S, Yoshizawa T, Asako S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Oba J, Nomura T, Sugita M. Angiotensin receptor blocker neprilysin inhibitors. World J Cardiol 2021; 13(8): 325-339 [PMID: 34589168 DOI: 10.4330/wjc.v13.i8.325] [Reference Citation Analysis]
61 Fausto BA, Badana ANS, Valdes OM, Athilingam P, Edwards JD. Examination of Heart Failure as a Predictor of Driving Cessation. J Transp Health 2017;7:202-8. [PMID: 29552488 DOI: 10.1016/j.jth.2017.10.003] [Reference Citation Analysis]
62 Meagher PB, Lee XA, Lee J, Visram A, Friedberg MK, Connelly KA. Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling. Cells 2021;10:770. [PMID: 33807373 DOI: 10.3390/cells10040770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Wakisaka M, Kamouchi M, Kitazono T. Lessons from the Trials for the Desirable Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Diabetic Cardiovascular Events and Renal Dysfunction. Int J Mol Sci 2019;20:E5668. [PMID: 31726765 DOI: 10.3390/ijms20225668] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
64 Gharzeddine R, McCarthy MM, Yu G, Dickson VV. Insomnia and Insomnia Symptoms in Persons With Heart Failure: An Integrative Review. J Cardiovasc Nurs 2020. [PMID: 32649375 DOI: 10.1097/JCN.0000000000000719] [Reference Citation Analysis]
65 Feyz L, Nannan Panday R, Henneman M, Verzijlbergen F, Constantinescu AA, van Dalen BM, Brugts JJ, Caliskan K, Geleijnse ML, Kardys I, Van Mieghem NM, Manintveld O, Daemen J. Endovascular renal sympathetic denervation to improve heart failure with reduced ejection fraction: the IMPROVE-HF-I study. Neth Heart J 2021. [PMID: 34609726 DOI: 10.1007/s12471-021-01633-z] [Reference Citation Analysis]
66 Aryan L, Medzikovic L, Umar S, Eghbali M. Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs. Biol Sex Differ 2020;11:14. [PMID: 32252821 DOI: 10.1186/s13293-020-00292-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
67 Lin Z, Chang J, Li X, Wang J, Wu X, Liu X, Zhu Y, Yu XY. Association of DNA methylation and transcriptome reveals epigenetic etiology of heart failure. Funct Integr Genomics 2021. [PMID: 34870779 DOI: 10.1007/s10142-021-00813-9] [Reference Citation Analysis]
68 Hensey M, O'Neill J. Is Heart Rate a Norepiphenomenon in Heart Failure? Curr Cardiol Rep 2016;18:91. [PMID: 27457085 DOI: 10.1007/s11886-016-0764-3] [Reference Citation Analysis]
69 Sandberg J, Olsson M, Ekström M. Underlying conditions contributing to breathlessness in the population. Curr Opin Support Palliat Care 2021;15:219-25. [PMID: 34610625 DOI: 10.1097/SPC.0000000000000568] [Reference Citation Analysis]
70 Manicam C, Ginter N, Li H, Xia N, Goloborodko E, Zadeh JK, Musayeva A, Pfeiffer N, Gericke A. Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice. Sci Rep 2017;7:7111. [PMID: 28769073 DOI: 10.1038/s41598-017-07768-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
71 Liao CT, Yang CT, Kuo FH, Lee MC, Chang WT, Tang HJ, Hua YM, Chang HY, Chen ZC, Strong C, Ou HT, Toh HS. Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region. Front Cardiovasc Med 2021;8:750381. [PMID: 34778407 DOI: 10.3389/fcvm.2021.750381] [Reference Citation Analysis]
72 Ahmed MK, Soliman MA, Reda AA, Abd El-ghani RS. Assessment of left atrial deformation properties by speckle tracking in patients with systolic heart failure. The Egyptian Heart Journal 2015;67:199-208. [DOI: 10.1016/j.ehj.2014.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
73 Rowlands RA, Cato MC, Waldschmidt HV, Bouley RA, Chen Q, Avramova L, Larsen SD, Tesmer JJG, White AD. Structure-Based Design of Selective, Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors. ACS Med Chem Lett 2019;10:1628-34. [PMID: 31857838 DOI: 10.1021/acsmedchemlett.9b00365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
74 Hanke N, Staggs L, Schroder P, Litteral J, Fleig S, Kaufeld J, Pauli C, Haller H, Schiffer M. “Zebrafishing” for novel genes relevant to the glomerular filtration barrier. Biomed Res Int. 2013;2013:658270. [PMID: 24106712 DOI: 10.1155/2013/658270] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
75 Liu Z, Chen T, Wei K, Liu G, Liu B. Similarity Changes Analysis for Heart Rate Fluctuation Regularity as a New Screening Method for Congestive Heart Failure. Entropy (Basel) 2021;23:1669. [PMID: 34945975 DOI: 10.3390/e23121669] [Reference Citation Analysis]
76 Schweiger V, Hasimbegovic E, Kastner N, Spannbauer A, Traxler D, Gyöngyösi M, Mester-Tonczar J. Non-Coding RNAs in Stem Cell Regulation and Cardiac Regeneration: Current Problems and Future Perspectives. Int J Mol Sci 2021;22:9160. [PMID: 34502068 DOI: 10.3390/ijms22179160] [Reference Citation Analysis]
77 Tuet WY, Racine MC, Jennings L, Pierce SA, Tressler J, Mccranor BJ, Wong B. A sex‐balanced rodent model for evaluating phosphine inhalation toxicity. Ann N Y Acad Sci 2020;1479:168-79. [DOI: 10.1111/nyas.14343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Carboni GP. Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy. Cardiol Res 2012;3:164-71. [PMID: 28348682 DOI: 10.4021/cr203w] [Reference Citation Analysis]
79 Ferreiro SF, Vilariño N, Carrera C, Louzao MC, Santamarina G, Cantalapiedra AG, Cifuentes JM, Crespo A, Botana LM. In vivo cardiomyocyte response to YTX- and AZA-1-induced damage: autophagy versus apoptosis. Arch Toxicol 2017;91:1859-70. [DOI: 10.1007/s00204-016-1862-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
80 Phyo AZZ, Ryan J, Gonzalez-Chica DA, Stocks NP, Reid CM, Tonkin AM, Woods RL, Nelson MR, Murray AM, Gasevic D, Freak-Poli R; ASPREE Investigator Group. Health-related quality of life and incident cardiovascular disease events in community-dwelling older people: A prospective cohort study. Int J Cardiol 2021;339:170-8. [PMID: 34245793 DOI: 10.1016/j.ijcard.2021.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Wang J, Li Z, Zhang Y, Liu X, Chen L, Chen Y. CX43 change in LPS preconditioning against apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation is associated with ERK signaling pathway. Mol Cell Biochem. 2013;380:267-275. [PMID: 23712704 DOI: 10.1007/s11010-013-1683-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
82 Wang W, Cai D. Complement Components sC5b-9 and CH50 Predict Prognosis in Heart Failure Patients Combined With Hypertension. Am J Hypertens 2020;33:53-60. [PMID: 31429866 DOI: 10.1093/ajh/hpz140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Nduhirabandi F, Maarman GJ. Melatonin in Heart Failure: A Promising Therapeutic Strategy? Molecules 2018;23:E1819. [PMID: 30037127 DOI: 10.3390/molecules23071819] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
84 Courelli V, Ahmad A, Ghassemian M, Pruitt C, Mills PJ, Schmid-Schönbein GW. Digestive Enzyme Activity and Protein Degradation in Plasma of Heart Failure Patients. Cell Mol Bioeng 2021;14:583-96. [PMID: 34900012 DOI: 10.1007/s12195-021-00693-w] [Reference Citation Analysis]
85 Veeneman RR, Vermeulen JM, Abdellaoui A, Sanderson E, Wootton RE, Tadros R, Bezzina CR, Denys D, Munafò MR, Verweij KJH, Treur JL. Exploring the Relationship Between Schizophrenia and Cardiovascular Disease: A Genetic Correlation and Multivariable Mendelian Randomization Study. Schizophr Bull 2021:sbab132. [PMID: 34730178 DOI: 10.1093/schbul/sbab132] [Reference Citation Analysis]
86 Oni-Orisan A, Lanfear DE. Pharmacogenomics in heart failure: where are we now and how can we reach clinical application? Cardiol Rev 2014;22:193-8. [PMID: 25093738 DOI: 10.1097/CRD.0000000000000028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
87 Wang J, Guo T. Metabolic remodeling in chronic heart failure. J Zhejiang Univ Sci B 2013;14:688-95. [PMID: 23897787 DOI: 10.1631/jzus.B1300137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wang Q, Xiao DD, Yan H, Zhao Y, Fu S, Zhou J, Wang Z, Zhou Z, Zhang M, Lu MJ. The morphological regeneration and functional restoration of bladder defects by a novel scaffold and adipose-derived stem cells in a rat augmentation model. Stem Cell Res Ther 2017;8:149. [PMID: 28646909 DOI: 10.1186/s13287-017-0597-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
89 Jafarinezhad Z, Rafati A, Ketabchi F, Noorafshan A, Karbalay-Doust S. Cardioprotective effects of curcumin and carvacrol in doxorubicin-treated rats: Stereological study. Food Sci Nutr 2019;7:3581-8. [PMID: 31763008 DOI: 10.1002/fsn3.1210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
90 van den Hoogen P, de Jager SCA, Huibers MMH, Schoneveld AH, Puspitasari YM, Valstar GB, Oerlemans MIFJ, de Weger RA, Doevendans PA, den Ruijter HM, Laman JD, Vink A, Sluijter JPG. Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure. J Cell Mol Med 2019;23:7505-16. [PMID: 31557411 DOI: 10.1111/jcmm.14619] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
91 Theidel U, Väätäinen S, Martikainen J, Soini E, Hardt T, Doehner W. Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany. ESC Heart Fail 2017;4:274-81. [PMID: 28772041 DOI: 10.1002/ehf2.12179] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
92 Tayanloo-Beik A, Roudsari PP, Rezaei-Tavirani M, Biglar M, Tabatabaei-Malazy O, Arjmand B, Larijani B. Diabetes and Heart Failure: Multi-Omics Approaches. Front Physiol 2021;12:705424. [PMID: 34421642 DOI: 10.3389/fphys.2021.705424] [Reference Citation Analysis]
93 Salazar J, Rojas-Quintero J, Cano C, Pérez JL, Ramírez P, Carrasquero R, Torres W, Espinoza C, Chacín-González M, Bermúdez V. Neprilysin: A Potential Therapeutic Target of Arterial Hypertension? Curr Cardiol Rev 2020;16:25-35. [PMID: 31241018 DOI: 10.2174/1573403X15666190625160352] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
94 Rudomanova V, Blaxall BC. Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies. Biochim Biophys Acta Mol Basis Dis 2017;1863:1883-92. [PMID: 28130200 DOI: 10.1016/j.bbadis.2017.01.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
95 Jenabi A, Mehdinavaz Aghdam R, Ebrahimi SAS, Ahmadi Tafti SH, Krishnan S, Suresh KS, Ramalingam M. Oxygen Delivery Approaches to Augment Cell Survival After Myocardial Infarction: Progress and Challenges. Cardiovasc Toxicol 2021. [PMID: 34542796 DOI: 10.1007/s12012-021-09696-5] [Reference Citation Analysis]
96 Colombe AS, Pidoux G. Cardiac cAMP-PKA Signaling Compartmentalization in Myocardial Infarction. Cells 2021;10:922. [PMID: 33923648 DOI: 10.3390/cells10040922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
97 Sbeit W, Kadah A, Mahamid M, Mari A, Khoury T. The interplay between gastrointestinal and cardiovascular diseases: a narrative review focusing on the clinical perspective. Eur J Gastroenterol Hepatol 2021;32:132-9. [PMID: 32516176 DOI: 10.1097/MEG.0000000000001779] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Binney N. The function of the heart is not obvious. Stud Hist Philos Biol Biomed Sci 2018;68-69:56-69. [PMID: 29798816 DOI: 10.1016/j.shpsc.2018.05.003] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Long B, Koyfman A, Gottlieb M. Diagnosis of Acute Heart Failure in the Emergency Department: An Evidence-Based Review. West J Emerg Med 2019;20:875-84. [PMID: 31738714 DOI: 10.5811/westjem.2019.9.43732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
100 Ge T, Qin H, Wang X, Yang S, Guo L, Han W, Chang H. Effects of Thoracic Epidural Anesthesia on Cardiac Function and Myocardial Cell Apoptosis in Isoproterenol-Induced Chronic Heart Failure Rats: EFFECTS OF THORACIC EPIDURAL ANESTHESIA ON CARDIAC FUNCTION AND MYOCARDIAL. J Int Cardiol 2014;27:446-55. [DOI: 10.1111/joic.12147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
101 Du J, Liu J, Zhen J, Yang S, Zheng E, Leng J. Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5. Biomedicine & Pharmacotherapy 2019;116:109028. [DOI: 10.1016/j.biopha.2019.109028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
102 Wang J, Xiao Y, Liu C, Huang Y, Petersen RB, Zheng L, Huang K. Emerging physiological and pathological roles of MeCP2 in non-neurological systems. Arch Biochem Biophys 2021;700:108768. [PMID: 33485848 DOI: 10.1016/j.abb.2021.108768] [Reference Citation Analysis]
103 Borovac JA, D'Amario D, Bozic J, Glavas D. Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers. World J Cardiol 2020; 12(8): 373-408 [PMID: 32879702 DOI: 10.4330/wjc.v12.i8.373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
104 Bacmeister L, Schwarzl M, Warnke S, Stoffers B, Blankenberg S, Westermann D, Lindner D. Inflammation and fibrosis in murine models of heart failure. Basic Res Cardiol 2019;114:19. [PMID: 30887214 DOI: 10.1007/s00395-019-0722-5] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 26.3] [Reference Citation Analysis]
105 Martinez J, Zoretic S, Moreira A, Moreira A. Safety and efficacy of cell therapies in pediatric heart disease: a systematic review and meta-analysis. Stem Cell Res Ther 2020;11:272. [PMID: 32641168 DOI: 10.1186/s13287-020-01764-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Perera R, Stevens R, Aronson JK, Banerjee A, Evans J, Feakins BG, Fleming S, Glasziou P, Heneghan C, Hobbs FR, Jones L, Kurtinecz M, Lasserson DS, Locock L, Mclellan J, Mihaylova B, O’callaghan CA, Oke JL, Pidduck N, Plüddemann A, Roberts N, Schlackow I, Shine B, Simons CL, Taylor CJ, Taylor KS, Verbakel JY, Bankhead C. Long-term monitoring in primary care for chronic kidney disease and chronic heart failure: a multi-method research programme. Programme Grants Appl Res 2021;9:1-218. [DOI: 10.3310/pgfar09100] [Reference Citation Analysis]
107 Jarkovská D, Miklovič M, Švíglerová J, Červenka L, Škaroupková P, Melenovský V, Štengl M. Effects of Trandolapril on Structural, Contractile and Electrophysiological Remodeling in Experimental Volume Overload Heart Failure. Front Pharmacol 2021;12:729568. [PMID: 34566652 DOI: 10.3389/fphar.2021.729568] [Reference Citation Analysis]
108 Lang H, Li Q, Yu H, Li P, Lu Z, Xiong S, Yang T, Zhao Y, Huang X, Gao P, Zhang H, Shang Q, Liu D, Zhu Z. Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function. Br J Pharmacol 2015;172:5548-58. [PMID: 25339153 DOI: 10.1111/bph.12987] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
109 Allara E, Morani G, Carter P, Gkatzionis A, Zuber V, Foley CN, Rees JMB, Mason AM, Bell S, Gill D, Lindström S, Butterworth AS, Di Angelantonio E, Peters J, Burgess S; INVENT consortium. Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation. Circ Genom Precis Med 2019;12:e002711. [PMID: 31756303 DOI: 10.1161/CIRCGEN.119.002711] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 10.7] [Reference Citation Analysis]
110 Aga F, Dunbar SB, Kebede T, Higgins MK, Gary R. Relationships of diabetes self-care behaviours to glycaemic control in adults with type 2 diabetes and comorbid heart failure. Nurs Open 2020;7:1453-67. [PMID: 32802365 DOI: 10.1002/nop2.517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Khoei SG, Dermani FK, Malih S, Fayazi N, Sheykhhasan M. The Use of Mesenchymal Stem Cells and their Derived Extracellular Vesicles in Cardiovascular Disease Treatment. Curr Stem Cell Res Ther 2020;15:623-38. [PMID: 32357818 DOI: 10.2174/1574888X15666200501235201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
112 Bartlett CS, Boyd KL, Harris RC, Zent R, Breyer RM. EP1 disruption attenuates end-organ damage in a mouse model of hypertension. Hypertension 2012;60:1184-91. [PMID: 23006735 DOI: 10.1161/HYPERTENSIONAHA.112.199026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
113 Nachman D, Asleh R, Amir O. Novel technologies in the management of heart failure with preserved ejection fraction: a promise during the time of disappointment from pharmacological approaches? Curr Opin Cardiol 2021;36:211-8. [PMID: 33394706 DOI: 10.1097/HCO.0000000000000829] [Reference Citation Analysis]
114 Perticone M, Zito R, Miceli S, Pinto A, Suraci E, Greco M, Gigliotti S, Hribal ML, Corrao S, Sesti G, Perticone F. Immunity, Inflammation and Heart Failure: Their Role on Cardiac Function and Iron Status. Front Immunol 2019;10:2315. [PMID: 31632400 DOI: 10.3389/fimmu.2019.02315] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
115 Yu H, Basu S, Hallow KM. Cardiac and renal function interactions in heart failure with reduced ejection fraction: A mathematical modeling analysis. PLoS Comput Biol 2020;16:e1008074. [PMID: 32804929 DOI: 10.1371/journal.pcbi.1008074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
116 Brenner S, Christa M, Berliner D, Deubner N, Ertl G, Held M, Marx A, Angermann CE, Störk S, Rutten FH, Güder G. Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction. International Journal of Cardiology 2017;227:727-33. [DOI: 10.1016/j.ijcard.2016.10.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
117 Okawa T, Aramaki Y, Yamamoto M, Kobayashi T, Fukumoto S, Toyoda Y, Henta T, Hata A, Ikeda S, Kaneko M, Hoffman ID, Sang BC, Zou H, Kawamoto T. Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure. J Med Chem 2017;60:6942-90. [PMID: 28699740 DOI: 10.1021/acs.jmedchem.7b00443] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
118 Larouche-Lebel É, Loughran KA, Oyama MA. Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease. J Vet Intern Med 2019;33:489-98. [PMID: 30793808 DOI: 10.1111/jvim.15461] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
119 Paschalis T, Jones C. Plasma HbA1c in the investigation of suspected heart failure in general practice: An audit of the 2018 NICE guidelines update. J Family Med Prim Care 2020;9:1098-102. [PMID: 32318474 DOI: 10.4103/jfmpc.jfmpc_917_19] [Reference Citation Analysis]
120 Hanif W, Alex L, Su Y, Shinde AV, Russo I, Li N, Frangogiannis NG. Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure. Cardiovasc Pathol 2017;30:27-37. [PMID: 28759817 DOI: 10.1016/j.carpath.2017.06.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
121 Binney N. The function of the heart is historically contingent. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 2018;68-69:42-55. [DOI: 10.1016/j.shpsc.2018.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Colin-Ramirez E, Arcand J, Ezekowitz JA. Dietary Self-management in Heart Failure: High Tech or High Touch? Curr Treat Options Cardiovasc Med 2017;19:19. [PMID: 28299612 DOI: 10.1007/s11936-017-0515-9] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
123 Hu D, Gu Y, Wu D, Zhang J, Li Q, Luo J, Li S, Yuan Z, Zhu B. Icariside II protects cardiomyocytes from hypoxia‑induced injury by upregulating the miR‑7‑5p/BTG2 axis and activating the PI3K/Akt signaling pathway. Int J Mol Med 2020;46:1453-65. [PMID: 32945347 DOI: 10.3892/ijmm.2020.4677] [Reference Citation Analysis]
124 Abu-elsaad NM, Abd Elhameed AG, El-karef A, Ibrahim TM. Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats. Journal of Medicinal Food 2015;18:950-9. [DOI: 10.1089/jmf.2014.0104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
125 Ferreiro SF, Carrera C, Vilariño N, Louzao MC, Santamarina G, Cantalapiedra AG, Botana LM. Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTX. Toxins (Basel) 2015;7:1030-47. [PMID: 25826053 DOI: 10.3390/toxins7041030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
126 Nikolic S, Dugic A, Steiner C, Tsolakis AV, Haugen Löfman IM, Löhr JM, Vujasinovic M. Chronic pancreatitis and the heart disease: Still terra incognita? World J Gastroenterol 2019; 25(44): 6561-6570 [PMID: 31802835 DOI: 10.3748/wjg.v25.i44.6561] [Cited by in CrossRef: 4] [Article Influence: 1.3] [Reference Citation Analysis]
127 Rodrigues FL, Lopes RAM, Fais RS, de Oliveira L, Prado CM, Tostes RC, Carneiro FS. Erectile dysfunction in heart failure rats is associated with increased neurogenic contractions in cavernous tissue and internal pudendal artery. Life Sciences 2016;145:9-18. [DOI: 10.1016/j.lfs.2015.12.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
128 Kaplan A, Abidi E, El-Yazbi A, Eid A, Booz GW, Zouein FA. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects. Heart Fail Rev 2018;23:419-37. [PMID: 29322280 DOI: 10.1007/s10741-017-9665-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 14.3] [Reference Citation Analysis]
129 Lo SH, Liu YC, Dai ZK, Chen IC, Wu YH, Hsu JH. Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy. Front Pediatr 2021;9:639551. [PMID: 33732669 DOI: 10.3389/fped.2021.639551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Nicolaou PA. Sex differences in heart failure medications targeting the renin-angiotensin-aldosterone system. Eur J Pharmacol 2021;897:173961. [PMID: 33617824 DOI: 10.1016/j.ejphar.2021.173961] [Reference Citation Analysis]
131 Ninh VK, El Hajj EC, Mouton AJ, El Hajj MC, Gilpin NW, Gardner JD. Chronic Ethanol Administration Prevents Compensatory Cardiac Hypertrophy in Pressure Overload. Alcohol Clin Exp Res 2018. [PMID: 29846943 DOI: 10.1111/acer.13799] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
132 Geng L, He C, Kan H, Zhang K, Mao A, Zhang C, Wang Z, Wei B, Zhou T, Wen X, Yu F, Li W, Feng L. The association between blood pressure levels and mortality in critically ill patients with COVID-19 in Wuhan, China: a case-series report. Hypertens Res 2021;44:368-70. [PMID: 33408331 DOI: 10.1038/s41440-020-00594-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Toninato R, Scuri S, Tarzia V, Gerosa G, Susin FM. In vitro performance investigation of SynCardia™ Freedom® driver via patient simulator mock loop. Int J Artif Organs 2016;39:502-8. [PMID: 27768204 DOI: 10.5301/ijao.5000524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
134 Balzan FM, da Silva RC, da Silva DP, Sanches PR, Tavares AM, Ribeiro JP, Berton DC, Clausell NO. Effects of diaphragmatic contraction on lower limb venous return and central hemodynamic parameters contrasting healthy subjects versus heart failure patients at rest and during exercise. Physiol Rep 2014;2:e12216. [PMID: 25501441 DOI: 10.14814/phy2.12216] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
135 Oka T, Akazawa H, Naito AT, Komuro I. Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure. Circ Res 2014;114:565-71. [PMID: 24481846 DOI: 10.1161/CIRCRESAHA.114.300507] [Cited by in Crossref: 216] [Cited by in F6Publishing: 136] [Article Influence: 27.0] [Reference Citation Analysis]
136 Abukar Y, Lever N, Pachen M, LeGrice IJ, Ramchandra R. Impaired Baroreflex Function in an Ovine Model of Chronic Heart Failure Induced by Multiple Coronary Microembolizations. Front Physiol 2019;10:1420. [PMID: 31824334 DOI: 10.3389/fphys.2019.01420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Weaver AM, Wellenius GA, Wu WC, Hickson DA, Kamalesh M, Wang Y. Residential Proximity to Major Roadways Is Not Associated with Cardiac Function in African Americans: Results from the Jackson Heart Study. Int J Environ Res Public Health 2016;13:E581. [PMID: 27304962 DOI: 10.3390/ijerph13060581] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
138 Buja LM, Ottaviani G, Mitchell RN. Pathobiology of cardiovascular diseases: an update. Cardiovasc Pathol 2019;42:44-53. [PMID: 31255975 DOI: 10.1016/j.carpath.2019.06.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
139 Barbeau PA, Houad JM, Huber JS, Paglialunga S, Snook LA, Herbst EAF, Dennis KMJH, Simpson JA, Holloway GP. Ablating the Rab-GTPase activating protein TBC1D1 predisposes rats to high-fat diet-induced cardiomyopathy. J Physiol 2020;598:683-97. [PMID: 31845331 DOI: 10.1113/JP279042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Abboud A, Januzzi JL. Reverse Cardiac Remodeling and ARNI Therapy. Curr Heart Fail Rep 2021;18:71-83. [DOI: 10.1007/s11897-021-00501-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
141 Otaal PS, Pachipala S, Uppal L, Bootla D. Correlation of Vitamin D Deficiency With Severity of Chronic Heart Failure as Assessed by Functional Class and N-Terminal Pro-Brain Natriuretic Peptide Levels. Cureus 2021;13:e13522. [PMID: 33786229 DOI: 10.7759/cureus.13522] [Reference Citation Analysis]
142 Wang X, Ji Y, Yang B. Chinese innovation in cardiovascular drug discovery. Br J Pharmacol 2015;172:5425-9. [PMID: 26629875 DOI: 10.1111/bph.13363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
143 Kessler EL, Boulaksil M, van Rijen HV, Vos MA, van Veen TA. Passive ventricular remodeling in cardiac disease: focus on heterogeneity. Front Physiol 2014;5:482. [PMID: 25566084 DOI: 10.3389/fphys.2014.00482] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
144 Yu P, Zhang B, Liu M, Yu Y, Zhao J, Zhang C, Li Y, Zhang L, Yang X, Jiang H, Zou Y, Ge J. Transcriptome Analysis of Hypertrophic Heart Tissues from Murine Transverse Aortic Constriction and Human Aortic Stenosis Reveals Key Genes and Transcription Factors Involved in Cardiac Remodeling Induced by Mechanical Stress. Dis Markers 2019;2019:5058313. [PMID: 31772688 DOI: 10.1155/2019/5058313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
145 Liu RC. Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan. Am J Cardiovasc Drugs 2018;18:473-82. [PMID: 29850980 DOI: 10.1007/s40256-018-0280-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Pallangyo P, Millinga J, Bhalia S, Mkojera Z, Misidai N, Swai HJ, Hemed NR, Kaijage A, Janabi M. Medication adherence and survival among hospitalized heart failure patients in a tertiary hospital in Tanzania: a prospective cohort study. BMC Res Notes 2020;13:89. [PMID: 32085803 DOI: 10.1186/s13104-020-04959-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
147 Kaluzna-Oleksy M, Sawczak F, Kukfisz A, Szczechla M, Krysztofiak H, Wleklik M, Przytarska K, Migaj J, Dudek M, Straburzyńska-Migaj E, Uchmanowicz I. Appetite and Nutritional Status as Potential Management Targets in Patients with Heart Failure with Reduced Ejection Fraction-The Relationship between Echocardiographic and Biochemical Parameters and Appetite. J Pers Med 2021;11:639. [PMID: 34357106 DOI: 10.3390/jpm11070639] [Reference Citation Analysis]
148 Boban M, Pesa V, Gabric ID, Manola S, Persic V, Antic-Kauzlaric H, Zulj M, Vcev A. Auxiliary diagnostic potential of ventricle geometry and late gadolinium enhancement in left ventricular non-compaction; non-randomized case control study. BMC Cardiovasc Disord 2017;17:286. [PMID: 29207943 DOI: 10.1186/s12872-017-0721-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
149 Weaver AM, Wellenius GA, Wu WC, Hickson DA, Kamalesh M, Wang Y. Residential distance to major roadways and cardiac structure in African Americans: cross-sectional results from the Jackson Heart Study. Environ Health 2017;16:21. [PMID: 28270143 DOI: 10.1186/s12940-017-0226-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
150 Tikunova SB, Cuesta A, Price M, Li MX, Belevych N, Biesiadecki BJ, Reiser PJ, Hwang PM, Davis JP. 3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP. J Gen Physiol 2019;151:9-17. [PMID: 30442775 DOI: 10.1085/jgp.201812131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
151 Sarhan NM, Shahin MH, El Rouby NM, El-Wakeel LM, Solayman MH, Langaee T, Khorshid H, Schaalan MF, Sabri NA, Cavallari LH. Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure. Clin Transl Sci 2020;13:195-203. [PMID: 31560448 DOI: 10.1111/cts.12702] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Georgiev KD, Hvarchanova N, Georgieva M, Kanazirev B. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients. Int J Clin Pharm 2019;41:1555-61. [PMID: 31595450 DOI: 10.1007/s11096-019-00918-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
153 Xian S, Yang Z, Lee J, Jiang Z, Ye X, Luo L, Jin L, Yang T, Ye S, Lu D. A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure. J Ethnopharmacol 2016;186:136-42. [PMID: 27045864 DOI: 10.1016/j.jep.2016.03.066] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
154 Xu G, Gaul MD, Liu Z, DesJarlais RL, Qi J, Wang W, Krosky D, Petrounia I, Milligan CM, Hermans A, Lu HR, Huang DZ, Xu JZ, Spurlino JC. Hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor. Bioorg Med Chem Lett 2020;30:127602. [PMID: 33038544 DOI: 10.1016/j.bmcl.2020.127602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Bowen GS, Diop MS, Jiang L, Wu W, Rudolph JL. A Multivariable Prediction Model for Mortality in Individuals Admitted for Heart Failure. J Am Geriatr Soc 2018;66:902-8. [DOI: 10.1111/jgs.15319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
156 Angelone T, Quintieri AM, Pasqua T, Filice E, Cantafio P, Scavello F, Rocca C, Mahata SK, Gattuso A, Cerra MC. The NO stimulator, Catestatin, improves the Frank-Starling response in normotensive and hypertensive rat hearts. Nitric Oxide 2015;50:10-9. [PMID: 26241941 DOI: 10.1016/j.niox.2015.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
157 Zhu Q, Li S, Ji K, Zhou H, Luo C, Sui Y. Differentially expressed TUG1 and miR-145-5p indicate different severity of chronic heart failure and predict 2-year survival prognosis. Exp Ther Med 2021;22:1362. [PMID: 34659508 DOI: 10.3892/etm.2021.10796] [Reference Citation Analysis]
158 Inoue T, Kobirumaki-Shimozawa F, Kagemoto T, Fujii T, Terui T, Kusakari Y, Hongo K, Morimoto S, Ohtsuki I, Hashimoto K, Fukuda N. Depressed Frank-Starling mechanism in the left ventricular muscle of the knock-in mouse model of dilated cardiomyopathy with troponin T deletion mutation ΔK210. J Mol Cell Cardiol 2013;63:69-78. [PMID: 23863340 DOI: 10.1016/j.yjmcc.2013.07.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
159 Gabriel-Costa D. The pathophysiology of myocardial infarction-induced heart failure. Pathophysiology 2018;25:277-84. [PMID: 29685587 DOI: 10.1016/j.pathophys.2018.04.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
160 Hendrickson T, Mancino C, Whitney L, Tsao C, Rahimi M, Taraballi F. Mimicking cardiac tissue complexity through physical cues: A review on cardiac tissue engineering approaches. Nanomedicine 2021;33:102367. [PMID: 33549819 DOI: 10.1016/j.nano.2021.102367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Herrera-Zelada N, Zuñiga-Cuevas U, Ramirez-Reyes A, Lavandero S, Riquelme JA. Targeting the Endothelium to Achieve Cardioprotection. Front Pharmacol 2021;12:636134. [PMID: 33603675 DOI: 10.3389/fphar.2021.636134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
162 Andrade D, Toledo C, Díaz H, Lucero C, Arce-álvarez A, Oliveira L, Takakura A, Moreira T, Schultz H, Marcus N, Alcayaga J, Del Rio R. Ablation of brainstem C1 neurons improves cardiac function in volume overload heart failure. Clinical Science 2019;133:393-405. [DOI: 10.1042/cs20180589] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
163 Andersen MB, Simonsen U, Wehland M, Pietsch J, Grimm D. LCZ696 (Valsartan/Sacubitril) - A Possible New Treatment for Hypertension and Heart Failure. Basic Clin Pharmacol Toxicol 2016;118:14-22. [DOI: 10.1111/bcpt.12453] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
164 de Almeida Salles T, Zogbi C, de Lima TM, de Godoi Carneiro C, Garcez AT, Barbeiro HV, Antonio EL, Dos Santos L, da Costa Pereira A, Tucci PJ, de Paula Faria D, Soriano FG, Girardi AC. The contributions of dipeptidyl peptidase IV to inflammation in heart failure. Am J Physiol Heart Circ Physiol 2016;310:H1760-72. [PMID: 27199127 DOI: 10.1152/ajpheart.00735.2015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
165 Siti HN, Jalil J, Asmadi AY, Kamisah Y. Effects of Quercetin on Cardiac Function in Pressure Overload and Postischemic Cardiac Injury in Rodents: a Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther 2020. [PMID: 33064235 DOI: 10.1007/s10557-020-07100-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
166 Chen J, Yaniz-galende E, Kagan HJ, Liang L, Hekmaty S, Giannarelli C, Hajjar R. Abnormalities of capillary microarchitecture in a rat model of coronary ischemic congestive heart failure. American Journal of Physiology-Heart and Circulatory Physiology 2015;308:H830-40. [DOI: 10.1152/ajpheart.00583.2014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
167 Aimo A, Castiglione V, Vergaro G, Panichella G, Senni M, Lombardi CM, Emdin M. The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction. Heart Fail Rev 2021. [PMID: 34291399 DOI: 10.1007/s10741-021-10146-1] [Reference Citation Analysis]
168 O'Dwyer J, Murphy R, González-Vázquez A, Kovarova L, Pravda M, Velebny V, Heise A, Duffy GP, Cryan SA. Translational Studies on the Potential of a VEGF Nanoparticle-Loaded Hyaluronic Acid Hydrogel. Pharmaceutics 2021;13:779. [PMID: 34067451 DOI: 10.3390/pharmaceutics13060779] [Reference Citation Analysis]
169 Zhou Q, Qin WZ, Liu SB, Kwong JS, Zhou J, Chen J. Shengmai (a traditional Chinese herbal medicine) for heart failure. Cochrane Database Syst Rev 2014;:CD005052. [PMID: 24733159 DOI: 10.1002/14651858.CD005052.pub5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
170 Kratky V, Vanourkova Z, Sykora M, Bacova BS, Hruskova Z, Kikerlova S, Huskova Z, Kopkan L. AT1 receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats. Sci Rep 2021;11:4271. [PMID: 33608612 DOI: 10.1038/s41598-021-83906-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Bahtiyar G, Gutterman D, Lebovitz H. Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus. Curr Diab Rep 2016;16:116. [PMID: 27730517 DOI: 10.1007/s11892-016-0809-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
172 Lin B, Feng DG, Xu J. microRNA-665 silencing improves cardiac function in rats with heart failure through activation of the cAMP signaling pathway. J Cell Physiol 2019;234:13169-81. [PMID: 30666648 DOI: 10.1002/jcp.27987] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
173 Campbell PT, Ryan J. Diuretic Dosing in Acute Decompensated Heart Failure: Lessons from DOSE. Curr Heart Fail Rep 2012;9:260-5. [DOI: 10.1007/s11897-012-0094-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
174 Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C, Albino-Teixeira A, Sousa T. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets. Front Physiol 2021;12:746494. [PMID: 34707513 DOI: 10.3389/fphys.2021.746494] [Reference Citation Analysis]
175 Guerrero-Beltrán CE, Mijares-Rojas IA, Salgado-Garza G, Garay-Gutiérrez NF, Carrión-Chavarría B. Peptidic vaccines: The new cure for heart diseases? Pharmacol Res 2021;164:105372. [PMID: 33316382 DOI: 10.1016/j.phrs.2020.105372] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
176 Chen J, Xu S, Wang L, Zhou W, Li P, Deng N, Tang Q, Li Y, Wu L, Chen J, Li W. Exendin-4 inhibits atrial arrhythmogenesis in a model of myocardial infarction-induced heart failure via the GLP-1 receptor signaling pathway. Exp Ther Med 2020;20:3669-78. [PMID: 32855719 DOI: 10.3892/etm.2020.9089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Franco J, Formiga F, Trullas JC, Salamanca Bautista P, Conde A, Manzano L, Quirós R, Franco ÁG, Ezquerro AM, Montero-Pérez-Barquero M; RICA investigators group. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure. Eur J Intern Med 2017;43:36-41. [PMID: 28499710 DOI: 10.1016/j.ejim.2017.05.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
178 Lombardi CM, Cimino G, Pagnesi M, Dell'Aquila A, Tomasoni D, Ravera A, Inciardi R, Carubelli V, Vizzardi E, Nodari S, Emdin M, Aimo A. Vericiguat for Heart Failure with Reduced Ejection Fraction. Curr Cardiol Rep 2021;23:144. [PMID: 34410527 DOI: 10.1007/s11886-021-01580-6] [Reference Citation Analysis]
179 Arellano DL. Reducing blood pressure in acute decompensated heart failure. Nurse Pract 2016;41:11-3. [PMID: 27332970 DOI: 10.1097/01.NPR.0000475372.70806.29] [Reference Citation Analysis]
180 Watson SR, Dormer JD, Fei B. Imaging technologies for cardiac fiber and heart failure: a review. Heart Fail Rev 2018;23:273-89. [PMID: 29500602 DOI: 10.1007/s10741-018-9684-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
181 Danielsen TK, Sadredini M, Manotheepan R, Aronsen JM, Frisk M, Hansen MH, Andressen KW, Hougen K, Levy FO, Louch WE, Sejersted OM, Sjaastad I, Stokke MK. Exercise Training Stabilizes RyR2-Dependent Ca2+ Release in Post-infarction Heart Failure. Front Cardiovasc Med 2020;7:623922. [PMID: 33569394 DOI: 10.3389/fcvm.2020.623922] [Reference Citation Analysis]
182 Guo X, Zhu C, Liu X, Ge Y, Jiang X, Zhao W. Hyperoside protects against heart failure-induced liver fibrosis in rats. Acta Histochem 2019;121:804-11. [PMID: 31353051 DOI: 10.1016/j.acthis.2019.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
183 Stansfield WE, Ranek M, Pendse A, Schisler JC, Wang S, Pulinilkunnil T, Willis MS. The Pathophysiology of Cardiac Hypertrophy and Heart Failure. Cellular and Molecular Pathobiology of Cardiovascular Disease. Elsevier; 2014. pp. 51-78. [DOI: 10.1016/b978-0-12-405206-2.00004-1] [Cited by in Crossref: 10] [Article Influence: 1.3] [Reference Citation Analysis]
184 Lucero CM, Andrade DC, Toledo C, Díaz HS, Pereyra KV, Diaz-Jara E, Schwarz KG, Marcus NJ, Retamal MA, Quintanilla RA, Del Rio R. Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats. Sci Rep 2020;10:6878. [PMID: 32327677 DOI: 10.1038/s41598-020-63336-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
185 Ferreiro SF, Vilariño N, Carrera C, Louzao MC, Cantalapiedra AG, Santamarina G, Cifuentes JM, Vieira AC, Botana LM. Subacute Cardiotoxicity of Yessotoxin: In Vitro and in Vivo Studies. Chem Res Toxicol 2016;29:981-90. [PMID: 27104637 DOI: 10.1021/acs.chemrestox.6b00012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
186 Toledo C, Andrade DC, Díaz HS, Pereyra KV, Schwarz KG, Díaz‐jara E, Oliveira LM, Takakura AC, Moreira TS, Schultz HD, Marcus NJ, Del Rio R. Rostral ventrolateral medullary catecholaminergic neurones mediate irregular breathing pattern in volume overload heart failure rats. J Physiol 2019;597:5799-820. [DOI: 10.1113/jp278845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
187 Januzzi JL, Butler J, Fombu E, Maisel A, Mccague K, Piña IL, Prescott MF, Riebman JB, Solomon S. Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF). American Heart Journal 2018;199:130-6. [DOI: 10.1016/j.ahj.2017.12.021] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
188 Ottaviani G, Radovancevic R, Kar B, Gregoric I, Buja LM. Pathological assessment of end-stage heart failure in explanted hearts in correlation with hemodynamics in patients undergoing orthotopic heart transplantation. Cardiovascular Pathology 2015;24:283-9. [DOI: 10.1016/j.carpath.2015.06.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
189 Januzzi JL Jr, Prescott MF, Butler J, Felker GM, Maisel AS, McCague K, Camacho A, Piña IL, Rocha RA, Shah AM, Williamson KM, Solomon SD; PROVE-HF Investigators. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. JAMA 2019;322:1085-95. [PMID: 31475295 DOI: 10.1001/jama.2019.12821] [Cited by in Crossref: 138] [Cited by in F6Publishing: 108] [Article Influence: 46.0] [Reference Citation Analysis]
190 Xia T, Chai X, Shen J. Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss. PLoS One. 2017;12:e0187804. [PMID: 29155861 DOI: 10.1371/journal.pone.0187804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
191 Michelhaugh SA, Januzzi JL Jr. Finding a Needle in a Haystack: Proteomics in Heart Failure. JACC Basic Transl Sci 2020;5:1043-53. [PMID: 33145466 DOI: 10.1016/j.jacbts.2020.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
192 Azman N, Zainudin NAIM, Ibrahim WNW. Fumonisin B1 Production by Fusarium Species and Mycotoxigenic Effect on Larval Zebrafish. Trop Life Sci Res 2020;31:91-107. [PMID: 33214858 DOI: 10.21315/tlsr2020.31.3.7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Gu W, Xu C, Li Z, Li ZZ. Echocardiographic changes in elderly patients with heart failure with reduced ejection fraction after sacubitril-valsartan treatment. Cardiovasc Diagn Ther 2021;11:1093-100. [PMID: 34815959 DOI: 10.21037/cdt-21-355] [Reference Citation Analysis]
194 Singh JS, Lang CC. Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond. Vasc Health Risk Manag. 2015;11:283-295. [PMID: 26082640 DOI: 10.2147/vhrm.s55630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
195 Song MK, Kim GB, Bae EJ, Lee YA, Kim H, Min S, Kim JH, Won J. Pheochromocytoma and paraganglioma in Fontan patients: Common more than expected. Congenital Heart Disease 2018;13:608-16. [DOI: 10.1111/chd.12625] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
196 Nielsen PM, Grimm D, Wehland M, Simonsen U, Krüger M. The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update. Basic Clin Pharmacol Toxicol 2018;122:9-18. [DOI: 10.1111/bcpt.12912] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
197 Zhu Y, Zou C, Jia Y, Zhang H, Ma X, Zhang J. Knockdown of circular RNA circMAT2B reduces oxygen-glucose deprivation-induced inflammatory injury in H9c2 cells through up-regulating miR-133. Cell Cycle 2020;19:2622-30. [PMID: 32897801 DOI: 10.1080/15384101.2020.1814025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Blackburn NJR, Vulesevic B, Mcneill B, Cimenci CE, Ahmadi A, Gonzalez-gomez M, Ostojic A, Zhong Z, Brownlee M, Beisswenger PJ, Milne RW, Suuronen EJ. Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction. Basic Res Cardiol 2017;112. [DOI: 10.1007/s00395-017-0646-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
199 Wu G, Wang Z, Shan P, Huang S, Lin S, Huang W, Huang Z. Suppression of Netrin-1 attenuates angiotension II-induced cardiac remodeling through the PKC/MAPK signaling pathway. Biomed Pharmacother 2020;130:110495. [PMID: 32688140 DOI: 10.1016/j.biopha.2020.110495] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]